The 4 Pinch Points Facing Global Clinical Trial Comparator Sourcing

Lead-time Inaccuracy, Continuity of Supply, Expiry Date Limitations and Waste

7

March

  • 2PM GMT / 3PM CET
  • Free

Why attend?

With less than two weeks to go before this “Turbo-Webinar,” the majority of registrants have selected “Ways to Avoid Continuity of Supply Issues” to be the topic discussed on the 7th March.

Naturally, the three other proposed topics will be highlighted where they touch upon Continuity of Supply.

 

Ways to Avoid Continuity of Supply Issues

(i) These are some of the implications for you when facing continuity of supply issues:

  • Unexpected delays to your planned completion date.
  • Recruited patients already receiving medication may need to drop out of your trial.
  • Newly recruited patients may lost to the trial if no initial medication is available.
  • You may incur significant unbudgeted costs to source from alternative markets.

 

(ii) These are some of the big, internal issues that you company will need to address:

  • The trial may have to be delayed or even cancelled if the comparator that you started the trial with is suddenly unavailable
  • The overall outcome of the trial will potentially be jeopardised if the trial does not use products consistent with the trial requirements
  • The market value of your organisation may be impacted if promised milestones are missed.

 

…and here are some of the solutions that can address these challenges:

  • Innovative dynamic inventory builds to ensure de-risked resupply
  • Built-in flexibility of sourcing & diversified supply options.
  • Provision of pre-planning market dynamics reviews to ensure that optimal sourcing strategy in adopted and maintained
  • Pro-active predictive market intelligence to navigate avoidable disruption to supply over the life of the trial.

 

The above and more will be discussed by Ian Hoban and Lucy Fox on the 7th March.

Speakers

Select a speaker to learn more

Back
Ian Hoban
Business Development Director - CTS, Abacus Medicine Pharma Services

Ian has 30 years of pharmaceutical industry experience, predominantly within global organisations such as Pfizer and Eli Lilly.  He built his reputation in the commercialisation of numerous brands in a variety of disease areas, and at every stage of the product lifecycle. 

During his career, Ian has worked closely with supply chain, ensuring accurate forecasting, and getting medicines to patients through the implementation of novel approaches.

Before joining Abacus Medicine Pharma Services Ian worked in senior roles at two leading Global Clinical Solutions companies.  He provided many leading pharmaceutical and biotechnology companies with successful Comparator Sourcing Solutions which helped successfully deliver their pivotal late phase clinical trials.

Next speaker
Back
Lucy Fox
Business Development Director, Abacus Medicine Pharma Services

After a successful ten year career with the Almac Group Lucy took some precious time away from the workplace to look after her young family. After three years she has now re-started her career within the Abacus Medicine Group and in September 2022 joined the Clinical Trial Solutions business unit of Abacus Medicine Pharma Services as a Business Development Director.

Lucy started her career within the clinical trial supply industry as a Business Development Co-ordinator where she supported multinational pharmaceutical, virtual and biotechnology companies to define their requirements for packaging, global distribution strategies and storage of clinical trial IMP.

After two years she was promoted and moved to Singapore as Business Development Manager, where she was a key member of Almac’s APAC commercial team. Here she was responsible for helping build the commercial and operational parts of the business in the Asia Pacific region and for advancing Almac’s reputation as a global leader in the provision of patient and trial supply management services.

Next speaker

Enquiry